Migliaccio et al. constructed a new PGR mutant that binds ligands but has no transcriptional activity and still stimulates the activation of c-Src and MAP kinases in breast cancer cells, suggesting that the PGR-cScr signaling pathway was functioning independently of transcriptional activation in the nucleus [47]. The gene discussed is PGR; the disease is breast cancer.